Cargando…
PS121. Evaluation of extrapyramidal side effects in the treatment of behavioral and psychological symptoms of dementia (BPSD): Interactions between anti-Alzheimer drugs and antidepressants
Autores principales: | Shimizu, Saki, Inada, Akiyoshi, Ohno, Yukihiro, Sogabe, Shunsaku, Yamanaka, Megumi, Yanagisako, Ryoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616717/ http://dx.doi.org/10.1093/ijnp/pyw043.121 |
Ejemplares similares
-
Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway
por: Shimizu, Saki, et al.
Publicado: (2017) -
PM432. Evaluation of the extrapyramidal side effects (EPS) liability of NMDA receptor glycine-binding site agonists
por: Ohno, Yukihiro, et al.
Publicado: (2016) -
Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects
por: Ohno, Yukihiro, et al.
Publicado: (2019) -
Akathisia as an Extrapyramidal Side Effect of Fluoxetine
por: Ajufo, Ijeoma, et al.
Publicado: (2021) -
Extrapyramidal side effects with low doses of amisulpride
por: Mandal, Nikhiles, et al.
Publicado: (2014)